Novo Nordisk insulin pricing litigation victory
We prevailed in having the complaint dismissed with prejudice
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Evergreen- and Brookfield-led consortium $16 billion acquisition of Nielsen
We are advising Brookfield on the transaction
Owens & Minor $600 million notes offering
The high-yield notes are due 2030
HP $3.3 billion acquisition of Poly
We are advising HP on the transaction
Home Depot $4 billion notes offering
The investment-grade notes are due 2025, 2027, 2032 and 2052
ING Groep $4 billion senior debt securities
The investment-grade notes are due 2026, 2028 and 2033
AN2 Therapeutics $69 million IPO
The shares are listed on the Nasdaq Global Select Market
Greencross Vets $1.1 billion dividend recapitalization
We advised the term lenders and agent on the financing
Banco Santander $2.75 billion senior preferred and non-preferred notes offering
We advised Banco Santander on its offering of fixed-rate and fixed-to-fixed-rate notes
British American Tobacco $200 million notes offering
The investment-grade notes are due 2032